Figure 1.
Figure 1. The event-free survival (EFS) of young adults ages 16–21 with acute lymphoblastic leukemia (ALL) treated on CCG and CALGB trials from 1988–1995.

The event-free survival (EFS) of young adults ages 16–21 with acute lymphoblastic leukemia (ALL) treated on CCG and CALGB trials from 1988–1995.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal